Effect of substance P on histamine secretion from gut mucosa in inflammatory bowel disease

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 5, 1999, Pages 496-503

  Raithel, M ^a   Schneider, H T ^a   Hahn, E G ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Histamine; Inflammatory bowel disease; Mucosal mast cells

Indexed keywords

HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; SUBSTANCE P;

ARTICLE; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; HISTAMINE RELEASE; HUMAN; HUMAN TISSUE; INTESTINE SECRETION; MALE; MAST CELL; PRIORITY JOURNAL; RECTUM BIOPSY; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; CULTURE TECHNIQUES; FEMALE; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; INTESTINAL MUCOSA; ISOANTIBODIES; MALE; MAST CELLS; MIDDLE AGED; STATISTICS, NONPARAMETRIC; SUBSTANCE P;

EID: 0033060541     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655299750026236     Document Type: Article

References (75)

1. Auer O, Pöder A, Fröhlich J. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets. Gastroenterology 1984;86:1531-43.
2. Halstensen ST, Mollnes TE, Garred P, Fausa O, Brandtzaeg P. Epithelial deposition of immunoglobulin GI and activated complement (C3b and terminal complement complex) in ulcerative colitis. Gastroenterology 1990;98:1264-71.
3. Katschinski B, Goebell H. Risikofaktoren in der Ätiologie des Morbus Crohn. Z. Gastroenterol 1990;28:368-72.
4. Kirsner BJ. Inflammatory bowel disease: its present and its future. Gastroenterology 1989;84:1358-61.
5. Purrmann J, Miller J, Strohmeyer G. Zur Ätiologie chronischentzündlicher Darmerkrankungen. Z Gastroenterol 1986;24:357-63.
6. Sachar DB. Inflammatory bowel disease: back to the future. Am J Gastroenterol 1990;85:373-6.
7. Knutson L, Ahrenstedt Ö, Odlind B, Hällgren R. The jejunal secretion of histamine is increased in active Crohn's disease. Gastroenterology 1990;98:549-554.
8. Raithel M, Hörauf A, Matek M, Baenkler HW. Kinetics of histamine released from rectal mucosa. Agents Actions 1989;28:164-7.
9. Raithel M, Hochberger J, Hahn EG. Effect of colonoscopy-premedication containing diazepam and pethidine on the release of mast cell mediators from gut mucosal samples. Endoscopy 1995;27:415-23.
10. Raithel M, Matek M, Baenkler HW, Jorde W, Hahn EG. Mucosal histamine content and histamine secretion in Crohn's disease, ulcerative colitis and allergic enteropathy. Int Arch Allergy Immunol 1995;108:127-33.
11. Fox CC, Lazenby AJ, Moore WC, Yardley JH, Bayless TM, Lichtenstein ML. Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 1990;99:119-24.
12. Nolte H, Spieldnaes N, Kruse A, Windelborg B. Histamine release from gut mast cells from patients with inflammatory bowel diseases. Gut 1990;31:791-4.
13. Eliakim R, Gilead L, Moshe L, Okon E, Rachmilewitz D, Razin E. Histamine and chondroitin sulfate E proteoglycan released by cultured human colonic mucosa; indication for possible presence of E mast cells. Proc Natl Acad Sci USA 1986;83:461-4.
14. Hörauf A, Raithel M, Baenkler HW, Matek M. Histamine release from human colonic mucosa in response to anti-IgE. Agents Actions 1989;27:89-92.
15. Dvorak AM, Monaham RA, Osage JE, Dickerson GR. Mast cell degranulation in Crohn's disease. Lancet 1979;1:498.
16. Marshall JS, Bienenstock J. Mast cells. Springer Semin Immunopathol 1990;12:191-202.
17. Hällgren R, Colombel JF, Dahl R, Fredens K, Kruse A, Jacobsen S, et al. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease. Studies on the secretion role and immunohistochemical localization of granulocyte granule constituents in jejunum. Am J Med 1989;86:56-64.
18. Ramos BF, Gureshi R, Olsen KM, Jakschik AB. The importance of mast cells for the neutrophil influx in immune complex induced peritonitis in mice. J Immunol 1990;145:1868-73.
19. Ali H, Leung KBP, Pearce FL, Hayes NA, Foremann JC. Comparison of the histamine-releasing action of substance P on mast cells and basophils from different species and tissues. Int Arch Allergy Appl Immunol 1986;79:413-8.
20. Shanahan F, Lee TDG, Bienenstock J, Befus AS. The influence of endorphins on peritoneal and mucosal mast cell secretion. J Allergy Clin Immunol 1984;74:499-504.
21. Johansson SGO. The future of allergy diagnostic techniques. Proceedings of EAACI Meeting 1990. Clin Exp Allergy 1991;21 Suppl 1:123-52.
22. Bueb JL, Mousli M, Landry Y. Molecular basis for cellular effects of naturally occuring polyamines. Agents Actions 1991;33:84-87.
23. Iwamoto I, Tomoe S, Tomioka H, Yoshida S. Substance P-induced granulocyte infiltration in mouse skin; the mast cell-dependent granulocyte infiltration by the N-terminal peptide is enhanced by the activation of vascular endothelial cells by the C-terminal peptide. Clin Exp Immunol 1992;87:203-7.
24. Lowman MA, Benyon RC, Church MK. Characterization of neuropeptide-induced histamine released from human dispersed skin mast cells. Br J Pharmacol 1988;95:121-30.
25. Stevens RL, Austen FK. Recent advances in cellular and molecular biology of mast cells. Immunology 1989;10:381-6.
26. Mantyh PW, Catton M, Maggio JE, Vigna SR. Alterations in receptors for sensory neuropeptides in human inflammatory bowel disease. Adv Exp Med Biol 1991;298:253-83.
27. Mazumdar S, Das KM. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease. Am J Gastroenterol 1992;87:176-81.
28. Newson B, Dahlström A, Enerbäck L, Ahlman H. Suggestive evidence for a direct innervation of mucosal mast cells. Neuroscience 1983;10:565-70.
29. Epstein FH. Mechanisms of disease: the enteric nervous system. N Engl J Med 1996;334:1106-15.
30. Mantyh CR, Vigna SR, Bollinger RR, Mantyh PW, Maggio JE, Pappas TN. Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis. Gastroenterology 1996;109:850-60.
31. Church MK, Benyon RC, Rees PH, Lowmann MA, Campbell AM, Robinson C, et al. Functional heterogeneity of human mast cells. In: Galli SJ, Austen KF, editors. Mast cell and basophil differentiation and function in health and disease. New York: Raven Press; 1989. p. 161-70.
32. Dotan I, Rachmilewitz D. Inflammatory mediators in inflammatory bowel disease. Curr Opin Gastroenterol 1998;14:295-9.
33. Koch TR, Carney JA, Go VLW. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel disease. Dig Dis Sci 1987;32:369-76.
34. Goldin E, Karmeli F, Selinger Z, Rachmilewitz D. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig Dis Sci 1989;34:754-7.
35. Koch TR, Carney JA, Go VLW. Gut regulatory peptides in Crohn's ilcitis (CI) and colitis (CC) [abstract]. Gastroenterology 1984;86:A1139.
36. Koch TR, Carney JA, Go VLW. Distribution and quantitation of gut peptides in normal colon and ulcerative colitis (UC) [abstract]. Gastroenterology 1984;86:A1139.
37. Yonei Y. Autonomic nervous alterations and mast cell degranulation in the exacerbation of ulcerative colitis. Gastroenterology 1987;84:1045.
38. Perdue MH, McKay DM. Mucosal regulators and immunopathophysiology. Curr Opin Gastroenterol 1996;12:591-9.
39. Stenson WF. Animal models of colitis. Curr Opin Gastroenterol 1995;11:310-5.
40. Hesterberg R, Sattler J, Lorenz W, Stahlknecht CD, Barth H, Crombach M, et al. Histamine content, diamine oxidase activity and histamine methyltransferase activity in human tissues: facts of fictions? Agents Actions 1984;14:325-34.
41. Raithel M, Pacurar A, Winterkamp S, Dalbay S, Ell C, Hahn EG. Analysis and characteristics of mast cell tryptase and eosinophilic cationic protein from human gut mucosa in gastrointestinal allergy. In: Wüthrich B, Ortolani C, editors. Highlights in food allergy. Monogr Allergy 1996;32:143-156.
42. Thon K, Lorenz W, Ohmann Ch, Weber D, Rohde H, Röher H. Sample taking problems in measuring actual histamine levels of human gastroduodenal mucosa: specific and general relevance in clinical trials on peptid ulcer pathogenesis and selective proximal vagotomy. Gut 1985;26:1165-78.
43. Wollin A, Navert H, Bounous G. Effect of intestinal ischemia on diamine oxidase activity in rat intestinal tissue and blood. Gastroenterology 1981;80:349-55.
44. Thompson JS, Bragg LE, West WW. Serum enzyme levels during intestinal ischemia. Ann Surg 1990;211;369-73.
45. Kusche J, Lorenz W, Stahlknecht CD, Richter H, Hesterberg R, Schmal A, et al. Intestinal diamine oxidase and histamine release in rabbit mesenteric ischemia. Gastroenterology 1981;80:980-7.
46. Kusche J, Lorenz W, Schmidt J. Oxidative deamination of biogenic amines by intestinal amino oxidase: histamine is specifically inactivated by diamine oxidase. Hoppe Seylers Z Physiol Chem 1975;356:1485-96.
47. Baenkler HW, Jorde W, Hörauf A, Raithel M. Antigen induzierte Histaminfreisetzung aus Kolonbiopsiepartikeln bei darmmanifester Allergie [Abstract]. Allergologie 1989;78:A2/12.
48. Raithel M, Hochberger J, Baenkler HW. Allergische Enteropathic-intestinal vermittelte Schimmelpilzallergie. Z Gastroenterol 1991;3:60-4.
49. Domschke S, Bloom SR, Adrian TE, Lux G, Domschke W. Chronic pancreatitis and diabetes mellitus; plasma and gastroduodenal mucosal profiles of regulatory peptides (gastrin, motilin, secretin, cholecystokinin, gastric inhibitory polypeptide, somatostatin, VIP, substance P, pancreatic polypeptide, glucagon, enteroglucagon, neurotensin). Hepatogastroenterology 1988;35:229-37.
50. McBride P, Bradley D, Kaliner M. Evaluation of a radioimmunoassay for histamine measurement in biologic fluids. J Allergy Clin Immunol 1988;82:638-46.
51. Luca de S, David B, Colin Y. A high sensitive radioimmunoassay for histamine in biological samples. Clin Chem 1986;32:1075.
52. Morel AM, Delaage MA. Immunoanalysis of histamine through a novel chemical derivatization. J Allergy Clin Immunol 1988;82:646-54.
53. Morel AM, Anfosso AJ, Delaage MA. Radioimmunoassay for histamine. Application to histamine release. J Allergy Clin Immunol 1985;75:124.
54. Ding E, Young J, Peterson CGB, Venge P, Cohn ZA. Mechanism of membrane damage mediated by human eosinophil cationic protein. Nature 1986;321:613-6.
55. Goldsmith P, McGarity B, Walls AF, Church MK, Millward-Sadler GH, Robertsom DA. Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig Dis Sci 1990;35:1409-13.
56. Herbay A, Gebbers JO, Otto HF. Immunopathology of ulcerative colitis: a review. Hepatogastroenterology 1990;37:99-107.
57. Jewell DP, Truelove SC. Reaginic hypersensitivity in ulcerative colitis. Gut 1972;13:903-6.
58. Kelleher D, Feighery C, Weir DG. Chemiluminescence by polymorphonuclear leucocyte subpopulations in chronic inflammatory bowel disease. Digestion 1990;45:158-65.
59. Kett K, Rognum TO, Brandtzaeg P. Mucosal subclass distribution of immunoglobulin G-producing cells is different in ulcerative colitis and Crohn's disease of the colon. Gastroenterology 1987;93:919-24.
60. Strobel S, Miller HRP, Ferguson A. Human intestinal mucosal mast cells: evaluation of fixation and staining techniques. J Clin Pathol 1981;34:851-8.
61. Elson CHO, Kagnoff MF, Fiocchi C, Befus AD, Targan St. Intestinal immunity and inflammation: recent progress. Gastroenterology 1986;91:746-86.
62. Fox CC, Dvorak AM, Peters SP, Kagey-Sobotka A, Lichtenstein LM. Isolation and characterization of human intestinal mucosal mast cells. J Immunol 1985;135:483-91.
63. Lloyd G, Green FHY, Fox H, Mani V, Turnberg LA. Mast cells and immunoglobulin E in inflammatory bowel disease. Gut 1975;16:861-6.
64. Stead RH, Dixon MF, Bramwell NH, Riddell RH, Bienenstock J. Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 1989;97:575-85.
65. Oestreicher P, Nielsen ST, Rainsford KD. Inflammatory bowel disease induced by combined bacterial immunization and oral carrageenan in guinea pigs. Dig Dis Sci 1991;36/4:461-70.
66. Lowman MA, Rees PH, Benyon RC, Church MK. Human mast cell heterogeneity: Histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli. J Allergy Clin Immunol 1988;81:590-7.
67. Mousli M, Bueb JL, Rouot B, Landry Y, Bronner C. G-proteins as targets for non-immunological histamine releasers. Agents Actions 1991;33:81-3.
68. Pullman EW, Elsbury S, Kobayashi M, Hapel AJ, Doe FW. Enhanced mucosal cytokine production in inflammatory bowel disease. Gastroenterology 1992;102:529-37.
69. Bischoff SC, Schwengberg S, Wordelmann K, Weinmann A, Raab R, Manns MP. Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls. Gut 1996;38:104-14.
70. Strobel S, Busuttel A, Ferguson A. Human intestinal mucosal mast cells: expanded population in untreated coeliac disease. Gut 1983;24:222-7.
71. Fox CC, Moore WC, Lichtenstein LM. Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid. Dig Dis Sci 1991;36:179-84.
72. Heatley RC, James PD. Eosinophils in the rectal mucosa. Gut 1978;20:787-91.
73. Beer DJ, Matloff MS, Rocklin RE. The influence of histamine on immune and inflammatory responses. Adv Immunol 1981;35:209-69.
74. Crowe SE, Perdue MH. Anti-immunoglobulin E-stimulated ion transport in human large and small intestine. Gastroenterology 1993;105:764-72.
75. Zweimann B. Mast cells in human disease. Clin Rev Allergy 1983;1:417-27.